REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $259,000 | -37.4% | 10,280 | -34.5% | 0.03% | -43.5% |
Q4 2021 | $414,000 | +77.7% | 15,700 | +579.7% | 0.05% | +64.3% |
Q3 2021 | $233,000 | -59.1% | 2,310 | -59.6% | 0.03% | -56.2% |
Q1 2021 | $570,000 | +125.3% | 5,713 | +252.9% | 0.06% | +68.4% |
Q2 2020 | $253,000 | -28.1% | 1,619 | -6.0% | 0.04% | -32.1% |
Q4 2019 | $352,000 | +46.1% | 1,722 | -42.6% | 0.06% | +33.3% |
Q3 2019 | $241,000 | -20.2% | 3,000 | -15.0% | 0.04% | -16.0% |
Q1 2019 | $302,000 | +39.8% | 3,531 | -64.4% | 0.05% | -13.8% |
Q4 2016 | $216,000 | – | 9,908 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
IFP Advisors, Inc | 300 | $51,708 | 0.00% |